BDSI

Biotechs Lead Higher

Stocks nudged higher on Monday, lead by a recovery in the biotechs. Trading volume eased a bit, taking some punch out of the move. Leading stocks outperformed slightly, but remain in their holding pattern. This group, of late, has been generally opening strong and then fading as the day goes on. I did notice some mild pickup in these shares […]

BioDelivery Sciences reports Q1 R&D costs $14.6M

moreView todays social media effects on BDSIView the latest stocks trending across Twitter. Click to view dashboardSee who BioDelivery is hiring next, click here to view […]

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials

[PR Newswire] – RALEIGH, N.C., May 8, 2014 /PRNewswire/ — BioDelivery Sciences International, Inc. (BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 with the U.S. Securities and Exchange Commission moreView todays social media effects on BDSIView the latest stocks trending across Twitter. Click to view dashboardSee who BioDelivery is […]

BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

[PR Newswire] – RALEIGH, N.C., May 8, 2014 /PRNewswire/ — BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank … moreView todays social media effects on BDSIView the latest stocks trending across Twitter. Click to view dashboardSee who BioDelivery is hiring next, click here to […]

BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy

[PR Newswire] – RALEIGH, N.C., May 6, 2014 /PRNewswire/ — BioDelivery Sciences International, Inc. (BDSI) announced that it has randomized more than half of the planned number of patients required for its ongoing initial Phase 3 study of Clonidine Topic moreView todays social media effects on BDSIView the latest stocks trending across Twitter. Click to view dashboardSee who BioDelivery is […]

BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference

[PR Newswire] – RALEIGH, N.C., Feb. 28, 2014 /PRNewswire/ — BioDelivery Sciences International, Inc. (BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Cowen and Company 34th Annual Health Care Co moreView todays social media effects on BDSIView the latest stocks trending across Twitter. Click to view dashboardSee who BioDelivery is […]